MARKET

EWTX

EWTX

Edgewise Therapeutics, Inc.
NASDAQ
23.74
+2.59
+12.24%
Opening 10:34 12/19 EST
OPEN
21.56
PREV CLOSE
21.15
HIGH
23.74
LOW
21.49
VOLUME
589.14K
TURNOVER
--
52 WEEK HIGH
35.50
52 WEEK LOW
10.60
MARKET CAP
2.51B
P/E (TTM)
-15.0517
1D
5D
1M
3M
1Y
5Y
1D
Tracking Baker Brothers Portfolio - Q3 2025 Update
Seeking Alpha · 3d ago
Weekly Report: what happened at EWTX last week (1208-1212)?
Weekly Report · 4d ago
Noteworthy Friday Option Activity: HROW, EWTX, RBLX
NASDAQ · 6d ago
Weekly Report: what happened at EWTX last week (1201-1205)?
Weekly Report · 12/08 09:39
Analysts Offer Insights on Healthcare Companies: Nano-X Imaging (NNOX), Edgewise Therapeutics (EWTX) and BioNTech SE (BNTX)
TipRanks · 12/04 13:20
Edgewise Therapeutics Grants Stock Options to New Employee Under Inducement Plan
Reuters · 12/02 13:02
EDGEWISE THERAPEUTICS REPORTS INDUCEMENT GRANTS AS PERMITTED BY THE NASDAQ LISTING RULES
Reuters · 12/02 13:00
Edgewise Therapeutics Reports Inducement Grants as permitted by the Nasdaq Listing Rules
PR Newswire · 12/02 13:00
More
About EWTX
Edgewise Therapeutics, Inc. is a muscle disease biopharmaceutical company developing novel therapeutics for muscular dystrophies and serious cardiac conditions. The Company’s lead product candidate, sevasemten (EDG-5506), is an orally administered skeletal myosin inhibitor in late-stage clinical trials in Becker and Duchenne muscular dystrophies. Its EDG-7500 is a novel cardiac sarcomere modulator for the treatment of hypertrophic cardiomyopathy and other diseases of diastolic dysfunction, which is in Phase II clinical development. The Company is using its proprietary drug discovery platform to develop a pipeline of precision medicine product candidates that target key muscle proteins and modulators to address a broad array of serious muscle disorders. Its platform utilizes custom-built high throughput and translatable systems that measure integrated muscle function in whole organ extracts to identify small molecule precision medicines regulating key proteins in muscle tissue.

Webull offers Edgewise Therapeutics Inc stock information, including NASDAQ: EWTX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, EWTX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading EWTX stock methods without spending real money on the virtual paper trading platform.